Agenus, Inc. (AGEN)
3.46
-0.10
(-2.81%)
USD |
NASDAQ |
Mar 26, 12:05
Agenus Cash from Investing (Quarterly) : 0.78M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Protalix Biotherapeutics, Inc. | -1.112M |
| CervoMed, Inc. | 5.374M |
| Curis, Inc. | 2.50M |
| Plus Therapeutics, Inc. | -1.077M |
| Windtree Therapeutics, Inc. | -0.789M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -16.62M |
| Cash from Financing (Quarterly) | 15.37M |
| Free Cash Flow | -77.20M |
| Free Cash Flow Per Share (Quarterly) | -0.4705 |
| Free Cash Flow to Equity (Quarterly) | -10.57M |
| Free Cash Flow to Firm (Quarterly) | -0.569M |
| Free Cash Flow Yield | -73.90% |